Behavioral Treatments for Speech in Parkinson’s Disease: Meta-Analyses and Review of the Literature
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) results from neurodegenerative processes leading to alteration of motor functions. Most motor symptoms respond well to pharmacological and neurosurgical treatments, except some axial symptoms such as speech impairment, so-called dysarthria. However, speech therapy is rarely proposed to PD patients. This review aims at evaluating previous research on the effects of speech behavioral therapies in patients with PD. We also performed two meta-analyses focusing on speech loudness and voice pitch. We showed that intensive therapies in PD are the most effective for hypophonia and can lead to some improvement of voice pitch. Although speech therapy is effective in handling PD dysarthria, behavioral speech rehabilitation in PD still needs further validation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Voice Handicap Index (VHI): Development and Validation
Jacobson, B. H., Johnson, A., Grywalski, C., Silbergleit, A., Jacobson, G., Benninger, M. S., & Newman, C. W. (1997) · American Journal of Speech-Language Pathology · doi:10.1044/1058-0360.0603.66 · Cited by 2,574
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Speech and language therapy for aphasia following stroke
Brady, M. C., Kelly, H., Godwin, J., Enderby, P., & Campbell, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000425.pub4 · Cited by 1,159
Closing the Gap between Methodologists and End-Users: R as a Computational Back-End
Wallace, B. C., Dahabreh, I. J., Trikalinos, T. A., Lau, J., Trow, P., & Schmid, C. H. (2012) · Journal of Statistical Software · doi:10.18637/jss.v049.i05 · Cited by 1,125
Why would Musical Training Benefit the Neural Encoding of Speech? The OPERA Hypothesis
Patel, A. D. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00142 · Cited by 703
Intensive voice treatment (LSVT(R)) for patients with Parkinson's disease: a 2 year follow up
Ramig, L. O. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.493 · Cited by 481
Speech Breathing in Parkinson’s Disease
Solomon, N. P., & Hixon, T. J. (1993) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3602.294 · Cited by 227
Constantinescu, G., Theodoros, D., Russell, T., Ward, E., Wilson, S., & Wootton, R. (2011) · International Journal of Language & Communication Disorders · doi:10.3109/13682822.2010.484848 · Cited by 192
Robertson, S. J., & Thomson, F. (1984) · International Journal of Language & Communication Disorders · doi:10.3109/13682828409029837 · Cited by 113
Pathomechanisms and compensatory efforts related to Parkinsonian speech
Arnold, C., Gehrig, J., Gispert, S., Seifried, C., & Kell, C. A. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.10.016 · Cited by 98
Cited by
Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
Ramig, L., Halpern, A., Spielman, J., Fox, C., & Freeman, K. (2018) · Movement Disorders · doi:10.1002/mds.27460 · Cited by 225
“The current findings, that improvements following voice treatment exceeded those following articulation (ES = 1.53) and no treatment (ES = 2.19), together with those of two earlier RCTs89,90 (ES = 0.65–2.03), build solid evidence for the efficacy of intensive treatment targeting voice for improving speech in PD. Movem…”
BackgroundInfluentialPu, T., Huang, M., Kong, X., Wang, M., Chen, X., Feng, X., Wei, C., Weng, X., & Xu, F. (2021) · Parkinson's Disease · doi:10.1155/2021/3366870 · Cited by 50
Misconceptions about speech impairment in Parkinson's disease
Moreau, C., & Pinto, S. (2019) · Movement Disorders · doi:10.1002/mds.27791 · Cited by 43
Self-citationEfficacy and Acceptance of a Lombard-response Device for Hypophonia in Parkinson’s Disease
Adams, S., Kumar, N., Rizek, P., Hong, A., Zhang, J., Senthinathan, A., Mancinelli, C., Knowles, T., & Jog, M. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.90 · Cited by 7
“PD is the second most common neurodegenerative disease with an estimated prevalence of between 1 and 3 per 100 people of 65 years and older,(2) and approximately 70% of individuals with PD will develop speech impairments.(3) One of the most prevalent and distinctive speech symptoms in idiopathic PD is hypophonia (redu…”
Background
Metadata
- Authors
- Atkinson-Clement, C., Sadat, J., & Pinto, S.
- Venue
- Neurodegenerative Disease Management
- Publisher
- Informa UK Limited
- Published
- 2015-06
- Volume
- 5
- Issue
- 3
- Pages
- 233-248
- ISSN
- 1758-2024 (ISSN-L)
- 1758-2032
- OpenAlex
- W2132061011
- Cited by
- 95
- References
- 14
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Behavioral Treatments for Speech in Parkinson’s Disease: Meta-Analyses and Review of the Literature. https://app.cochat.ai/papers/10.2217/nmt.15.16
- The paper
- Atkinson-Clement, C., Sadat, J., & Pinto, S. (2015). Behavioral Treatments for Speech in Parkinson’s Disease: Meta-Analyses and Review of the Literature. Neurodegenerative Disease Management. https://doi.org/10.2217/nmt.15.16
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.